日本小林製藥紅麴問題：死亡個案可能增至76人

Reported 9 months ago

日本厚生勞動省收到79人服用小林製藥問題紅麴保健食品後死亡的報告，其中有3人的死亡被認定與食品無關，餘下的76人仍在調查中。報導指出，至今小林製藥公布的死亡人數為5人。許多服用後出現腎臟問題的民眾顯示疑似與尿細管損傷有關的症狀和檢查結果。

You may also interested in these wikis

KKR and Warburg Pincus Group Make Non-Binding Bid for Gerresheimer

Thailand Approves $2.7 Billion Investment in Data Centers and Cloud Services

Watch Nvidia GTC 2025: Keynote by CEO Jensen Huang

Indonesian Stocks Experience Largest Drop Since 2011 Amid Economic Concerns

Grab Advances Talks to Acquire Rival GoTo

New Investment Opportunities Emerge Amid Tech Market Weakness

Cathie Wood Reduces Meta Holdings for the First Time in Almost a Year

Alphabet to Acquire Cybersecurity Startup Wiz for $32 Billion

Trump Confirms No Exemptions for Steel and Aluminum Tariffs Amid Trade Tensions

Intel's New CEO Faces Challenges Amid Stock Surge

Back to all Wikis